Clinical Trial

A Phase 1 Clinical Study in Healthy Participants

Name: A Phase 1 Clinical Study in Healthy Participants — clinical trial record (NCT07584876)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered BW-41012 in Healthy Participants

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-10

Trial Details

NCT Number	NCT07584876
Lead Sponsor	Shanghai Argo Biopharmaceutical Co., Ltd.
Conditions	HV
Enrollment	40 participants
Start Date	2026-05-29
Primary Completion	2027-10-30 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-09